HEADER RNA BINDING PROTEIN 24-FEB-03 1O0P TITLE SOLUTION STRUCTURE OF THE THIRD RNA RECOGNITION MOTIF (RRM) OF U2AF65 TITLE 2 IN COMPLEX WITH AN N-TERMINAL SF1 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPLICING FACTOR U2AF 65 KDA SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL RRM DOMAIN; COMPND 5 SYNONYM: U2 AUXILIARY FACTOR 65 KDA SUBUNIT, U2 SNRNP AUXILIARY COMPND 6 FACTOR LARGE SUBUNIT, HU2AF(65); COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: SPLICING FACTOR SF1; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: N-TERMINAL PEPTIDE; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 DE3; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: MODIFIED PET24D; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED AND DERIVED SOURCE 13 FROM THE N-TERMINUS OF SF1. THE SEQUENCE OF THE PEPTIDE IS NATURALLY SOURCE 14 FOUND IN HOMO SAPIENS (HUMAN). KEYWDS NON-CANONICAL RNA RECOGNITION MOTIF, 4-STRANDED ANTI-PARALLEL BETA- KEYWDS 2 SHEET, 2 ALPHA HELICES ADDITIONALLY EXTENDED BY A THIRD HELIX C, RNA KEYWDS 3 BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR P.SELENKO,G.GREGOROVIC,R.SPRANGERS,G.STIER,Z.RHANI,A.KRAMER,M.SATTLER REVDAT 3 23-FEB-22 1O0P 1 REMARK REVDAT 2 24-FEB-09 1O0P 1 VERSN REVDAT 1 06-MAY-03 1O0P 0 JRNL AUTH P.SELENKO,G.GREGOROVIC,R.SPRANGERS,G.STIER,Z.RHANI,A.KRAMER, JRNL AUTH 2 M.SATTLER JRNL TITL STRUCTURAL BASIS FOR THE MOLECULAR RECOGNITION BETWEEN HUMAN JRNL TITL 2 SPLICING FACTORS U2AF65 AND SF1/MBBP JRNL REF MOL.CELL V. 11 965 2003 JRNL REFN ISSN 1097-2765 JRNL PMID 12718882 JRNL DOI 10.1016/S1097-2765(03)00115-1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NMRPIPE 2.1, CNS 1.1 REMARK 3 AUTHORS : DELAGIO (NMRPIPE), BRUNGER (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THE EXPERIMENTALLY DETERMINED DISTANCE (3232 NOES, INCLUDING 258 REMARK 3 FOR THE SF1 PEPTIDE, 64 INTERMOLECULAR, AND 2*35 FOR HYDROGEN REMARK 3 BONDS) AND DIHEDRAL ANGLE RESTRAINTS (99) WERE APPLIED IN A MIXED REMARK 3 TORSION AND CARTESIAN ANGLE DYNAMICS/SIMULATED ANNEALING PROTOCOL. REMARK 3 STRUCTURAL QUALITY WAS ASSESED WITH PROCHECK. REMARK 4 REMARK 4 1O0P COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-FEB-03. REMARK 100 THE DEPOSITION ID IS D_1000018428. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 295 REMARK 210 PH : 6.4 REMARK 210 IONIC STRENGTH : 50MM SALT REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1MM 15N,13C U2AF65-RRM3 + 1MM REMARK 210 UNLABELED SF1_10-25, 30MM REMARK 210 PHOSPHATE BUFFER, 20MM NACL, 3MM REMARK 210 DTT; 1MM 15N,13C U2AF65-RRM3 + REMARK 210 1MM UNLABELED SF1_10-25, 30MM REMARK 210 PHOSPHATE BUFFER, 20MM NACL, 3MM REMARK 210 DTT REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_13C-SEPARATED_NOESY; 3D_15N REMARK 210 -SEPARATED_NOESY; 3D_13C/15N- REMARK 210 EDITED/FILTERED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 500 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XEASY, ARIA 1.2, CNS 1.1 REMARK 210 METHOD USED : RESTRAINED MOLECULAR DYNAMICS REMARK 210 USING CNS AND ARIA FOR AMBIGUOUS REMARK 210 DISTANCE RESTRAINTS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS,STRUCTURES REMARK 210 WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 HIS A 373 122.05 -172.47 REMARK 500 1 THR A 375 -72.62 -120.79 REMARK 500 1 GLU A 376 -38.02 -177.75 REMARK 500 1 LEU A 389 34.05 -85.30 REMARK 500 1 PRO A 427 92.12 -47.63 REMARK 500 1 ARG A 452 -141.48 -75.53 REMARK 500 1 ALA A 455 -52.11 -162.62 REMARK 500 1 ASN A 456 13.68 -163.64 REMARK 500 1 ASP A 467 -77.52 -64.63 REMARK 500 1 PHE A 474 -79.35 -89.61 REMARK 500 1 SER B 14 -173.50 59.51 REMARK 500 1 LYS B 15 -35.95 -161.29 REMARK 500 1 LYS B 16 -51.68 -135.24 REMARK 500 1 SER B 20 49.89 -147.12 REMARK 500 1 TRP B 22 87.48 53.82 REMARK 500 1 GLN B 24 -44.85 -167.59 REMARK 500 2 HIS A 373 109.59 -176.69 REMARK 500 2 THR A 375 -67.94 -141.13 REMARK 500 2 GLU A 376 -47.24 -173.09 REMARK 500 2 ASP A 422 19.65 56.67 REMARK 500 2 PRO A 427 38.01 -94.28 REMARK 500 2 ALA A 455 -46.19 -152.25 REMARK 500 2 ASN A 456 13.79 -162.39 REMARK 500 2 ASP A 467 -71.74 -64.54 REMARK 500 2 PHE A 474 -75.92 -63.91 REMARK 500 2 LYS B 15 55.99 -141.41 REMARK 500 2 ARG B 17 86.29 56.84 REMARK 500 2 LYS B 18 -48.04 -163.18 REMARK 500 2 SER B 20 56.63 -102.30 REMARK 500 2 ARG B 21 -175.48 59.91 REMARK 500 2 ASN B 23 -79.54 -64.98 REMARK 500 2 GLN B 24 127.24 64.41 REMARK 500 3 HIS A 373 90.04 65.16 REMARK 500 3 THR A 375 -69.53 -108.22 REMARK 500 3 GLU A 376 -45.62 -176.39 REMARK 500 3 MET A 383 -28.81 -167.35 REMARK 500 3 LEU A 389 38.22 -86.22 REMARK 500 3 VAL A 421 96.18 -68.65 REMARK 500 3 GLU A 425 35.67 -81.13 REMARK 500 3 PRO A 427 79.59 -66.09 REMARK 500 3 ARG A 452 -160.56 -77.85 REMARK 500 3 ALA A 455 -41.08 -166.18 REMARK 500 3 ASN A 456 26.76 -167.31 REMARK 500 3 ASP A 467 -73.70 -59.93 REMARK 500 3 SER B 14 -164.70 -70.58 REMARK 500 3 LYS B 15 -73.16 -102.42 REMARK 500 3 LYS B 16 -37.44 -156.92 REMARK 500 3 GLN B 24 132.13 65.61 REMARK 500 4 HIS A 373 134.50 -172.91 REMARK 500 4 THR A 375 -69.86 -120.50 REMARK 500 REMARK 500 THIS ENTRY HAS 175 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 1O0P A 372 475 UNP P26368 U2AF2_HUMAN 372 475 DBREF 1O0P B 13 25 GB 2463198 CAA03883 13 25 SEQRES 1 A 104 GLY HIS PRO THR GLU VAL LEU CYS LEU MET ASN MET VAL SEQRES 2 A 104 LEU PRO GLU GLU LEU LEU ASP ASP GLU GLU TYR GLU GLU SEQRES 3 A 104 ILE VAL GLU ASP VAL ARG ASP GLU CYS SER LYS TYR GLY SEQRES 4 A 104 LEU VAL LYS SER ILE GLU ILE PRO ARG PRO VAL ASP GLY SEQRES 5 A 104 VAL GLU VAL PRO GLY CYS GLY LYS ILE PHE VAL GLU PHE SEQRES 6 A 104 THR SER VAL PHE ASP CYS GLN LYS ALA MET GLN GLY LEU SEQRES 7 A 104 THR GLY ARG LYS PHE ALA ASN ARG VAL VAL VAL THR LYS SEQRES 8 A 104 TYR CYS ASP PRO ASP SER TYR HIS ARG ARG ASP PHE TRP SEQRES 1 B 13 PRO SER LYS LYS ARG LYS ARG SER ARG TRP ASN GLN ASP HELIX 1 1 ASP A 391 SER A 407 1 17 HELIX 2 2 SER A 438 THR A 450 1 13 HELIX 3 3 ASP A 465 ARG A 472 1 8 SHEET 1 A 4 VAL A 412 GLU A 416 0 SHEET 2 A 4 LYS A 431 PHE A 436 -1 O GLU A 435 N SER A 414 SHEET 3 A 4 VAL A 377 MET A 381 -1 N LEU A 378 O VAL A 434 SHEET 4 A 4 VAL A 460 CYS A 464 -1 O VAL A 460 N MET A 381 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1